Skip to Content

Join the 'Suboxone' group to help and get support from people like you.

Suboxone News

Many Drugstores Won't Dispense Opioid Antidote Naloxone as Required

Posted 13 Nov 2018 by Drugs.com

TUESDAY, Nov. 13, 2018 – People who overdose on opioids have one lifeline, the drug naloxone, but two new studies find that many pharmacies won't offer this lifesaving antidote without a doctor's blessing. Though many states have passed laws mandating that naloxone be made available without a prescription, researchers from California found that fewer than 25 percent of pharmacies in that state ...

FDA Approves Cassipa (buprenorphine and naloxone) Sublingual Film as Maintenance Treatment for Opioid Dependence

Posted 10 Sep 2018 by Drugs.com

September 7, 2018 – The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence. This action provides a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film, which is also approved in both brand name and generic versions and in ...

Naloxone Nasal Spray Works Best to Stop Opioid OD: Study

Posted 8 Sep 2018 by Drugs.com

FRIDAY, Sept. 7, 2018 – A one-step nasal spray is the easiest form of naloxone to give someone suffering an opioid overdose, researchers say. Increased public availability of naloxone, also known by the brand name Narcan, is considered a key way to reduce opioid overdose deaths. But there's more than one way to administer it, and it wasn't clear which method would be most successful when given ...

FDA takes action against 21 websites marketing unapproved opioids as part of agency’s effort to target illegal online sales

Posted 28 Aug 2018 by Drugs.com

August 28, 2018 – The U.S. Food and Drug Administration today announced it has warned four more online networks, operating a total of 21 websites, illegally marketing potentially dangerous, unapproved, and misbranded versions of opioid medications, including tramadol. The warning letters issued by the FDA to each of the networks state that they must immediately stop illegally selling these ...

Treatment for Opioid Abuse Grows, but Many on Medicaid Don't Receive It

Posted 2 Jul 2018 by Drugs.com

MONDAY, July 2, 2018 – Approval of the drug buprenorphine led to a rise in the number of Medicaid patients getting medication to treat opioid addiction. But the rates were lower among poor, black and Hispanic patients, a new study says. Methadone or buprenorphine are recommended treatments for opioid-abuse disorders. Methadone must be dispensed in special clinics and often requires daily visits, ...

Kids Are Overdosing on Buprenorphine, A Med Meant to Fight Opioid Addiction

Posted 25 Jun 2018 by Drugs.com

MONDAY, June 25, 2018 – Young American children are being sickened – and even dying – after being poisoned by a drug used to fight opioid addiction, a new report contends. Investigators reported that between 2007 and 2016, more than 11,000 emergency calls were made to U.S. poison control centers after a child or teen was exposed to buprenorphine, a powerful prescription medication that helps ...

If Opioid Addicts Survive OD, Other Hazards Lie Ahead: Study

Posted 20 Jun 2018 by Drugs.com

WEDNESDAY, June 20, 2018 – Survivors of an opioid overdose may consider themselves lucky, but they remain at heightened risk of dying – not just from drugs, but from a host of medical problems or suicide, a new study finds. Compared with the general population, patients who lived through an opioid overdose were 130 times more likely to die of drug-use-related causes in the following year, the ...

FDA Approves First Generic Versions of Suboxone Sublingual Film, Which May Increase Access to Treatment for Opioid Dependence

Posted 15 Jun 2018 by Drugs.com

June 14, 2018 – The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. “The FDA is taking new steps to advance the development of improved treatments for opioid use disorder, and to make sure these medicines are accessible to the patients who need t ...

Hit Hard by Opioid Crisis, Appalachian States Expand Clean-Needle Programs

Posted 11 May 2018 by Drugs.com

FRIDAY, May 11, 2018 – In 2013, there was just one clean-needle program in all of West Virginia, Kentucky and North Carolina, and the latter two states had laws banning such programs. Fast-forward four years: All of those laws have now been overturned and the number of "syringe services programs" available to help addicts has risen to over 50 across the three states, researchers report. ...

Addicts Should Be Trained to Give OD Antidote, Naloxone, Study Finds

Posted 5 Apr 2018 by Drugs.com

THURSDAY, April 5, 2018 – Frequent opioid users may be the best candidates for training to reverse overdoses in other users, researchers say. The U.S. opioid crisis has led many public health departments and community groups to begin training users on the use of the opioid-blocker naloxone. In a new study, a team from Johns Hopkins Bloomberg School of Public Health in Baltimore examined ways to ...

U.S. Courts, Jails Could Be Key Players in Curbing Opioid Abuse

Posted 7 Dec 2017 by Drugs.com

WEDNESDAY, Dec. 6, 2017 – Just 5 percent of people referred for opioid addiction treatment by the U.S. criminal justice system receive the best treatment, a new study finds. Use of medications such as methadone and buprenorphine is considered the most effective way to treat opioid addiction, said researchers from the Johns Hopkins Bloomberg School of Public Health. The drugs help control the ...

Once-Monthly Injection, Sublocade (buprenorphine) Approved for Opioid Addiction

Posted 1 Dec 2017 by Drugs.com

FRIDAY, Dec. 1, 2017 – Sublocade, a once-monthly injection of buprenorphine to treat opioid use disorder, has been approved by the U.S. Food and Drug Administration. Opioid abuse is diagnosed when a person's pattern of opioid use leads to "significant impairment or distress and includes signs and symptoms that reflect compulsive, prolonged self-administration of opioid substances for no ...

FDA Approves Monthly Dose of Opioid Addiction Treatment, Buprenorphine

Posted 1 Dec 2017 by Drugs.com

FRIDAY, Dec. 1, 2017 – A once-monthly injection of the opioid addiction drug buprenorphine has been approved by the U.S. Food and Drug Administration. "Millions of Americans are suffering from addiction to opioid drugs, and millions more are worried that the overdose epidemic could claim the lives of a friend or loved one," FDA Commissioner Dr. Scott Gottlieb said Thursday in an agency news ...

Chronic Pain Common Among Those Who OD on Opioids

Posted 28 Nov 2017 by Drugs.com

TUESDAY, Nov. 28, 2017 – More than 60 percent of opioid overdose deaths involve people who suffer from chronic pain, a new analysis reveals. Many of them also struggled with depression or anxiety, the investigators found. The findings stem from a study that examined the medical backgrounds of more than 13,000 men and women who died from an opioid overdose between 2001 and 2007. "The frequent ...

Top Meds To Treat Opioid Addiction Equally Safe, Effective

Posted 15 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 15, 2017 – The top two medications used to treat opioid addiction appear equally safe and effective, a new study finds. With the United States in the midst of an unprecedented opioid crisis, researchers conducted a head-to-head trial of two leading addiction treatments – naltrexone (Vivitrol) and buprenorphine-naloxone (Suboxone). "The newer drug, naltrexone, was as effective in ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Opiate Dependence

Suboxone Patient Information at Drugs.com